Case report of HFE gene testing for the diagnosis of hereditary hemochromatosis

Journal of Digestive Diseases

Volumn 12, Issue 5, 2011, Pages 409-411

  Pan, Hui Yun ^a   Wang, Li Jun ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; GLUCOSE; HFE PROTEIN; IRON; TRANSFERRIN;

AGED; ANTICOAGULATION; APPETITE DISORDER; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE REPORT; DISEASE COURSE; FATIGUE; GENE; GENE IDENTIFICATION; GENETIC SCREENING; GLUCOSE BLOOD LEVEL; HEMOCHROMATOSIS; HEREDITARY HEMOCHROMATOSIS; HISTOPATHOLOGY; HUMAN; IRON BLOOD LEVEL; LIVER BIOPSY; LIVER HEMOSIDEROSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TRANSFERRIN BLOOD LEVEL;

AGED; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MEMBRANE PROTEINS;

EID: 80053430845     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2011.00515.x     Document Type: Article

References (14)

1. Schmitt B, Aronson M, Fitterman N, Snow V, Weiss K, Owens D. Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: systematic review for the American College of Physicians. Ann Intern Med 2005; 143: 522-36.
2. Olynyk J, Trinder D, Ramm G, Britton R, Bacon B. Hereditary hemochromatosis in the post-HFE era. Hepatology 2008; 48: 991-1001.
3. Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease. N Engl J Med 2004; 350: 2383-97.
4. McLaren GD, Gordeuk VR. Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Hematology Am Soc Hematol Educ Program 2009: 195-206.
5. Chandrasekharan S, Pitlick E, Heaney C, Cook-Deegan R. Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis. Genet Med 2010; 12: S155-S170.
6. Simon M, Le Mignon L, Fauchet R etal. A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association. Am J Hum Genet 1987; 41: 89-105.
7. Feder JN, Gnirke A, Thomas W etal. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408.
8. Gochee PA, Powell LW, Cullen DJ, Du Sart D, Rossi E, Olynyk JK. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology 2002; 122: 646-51.
9. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJ. Geography of HFE C282Y and H63D mutations. Genet Test 2000; 4: 183-98.
10. Clark P, Britton LJ, Powell LW. The diagnosis and management of hereditary haemochromatosis. Clin Biochem Rev 2010; 31: 3-8.
11. O'Neil J, Powell L. Clinical aspects of hemochromatosis. Semin Liver Dis 2005; 25: 381-91.
12. Tavill AS; American Association for the Study of Liver Diseases; American College of Gastroenterology; American Gastroenterological Association. Diagnosis and management of hemochromatosis. Hepatology 2001; 33: 1321-8.
13. Falize L, Guillygomarc'h A, Perrin M etal. Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases. Hepatology 2006; 44: 472-7.
14. Powell L, Dixon J, Ramm G etal. Screening for hemochromatosis in asymptomatic subjects with or without a family history. Arch Intern Med 2006; 166: 294-301.